Medicarecard.com MedicareCard Replacement Medicare Card, Study shows promise of precision medicine for most common type of lymphoma

Medicare Card, Study shows promise of precision medicine for most common type of lymphoma

Lymphomas are caused by an abnormal proliferation of white blood cells and can occur at any age.  A clinical trial has shown that patients with a specific molecular subtype of diffuse large B-cell lymphoma (DLBCL) are more likely to respond to the drug ibrutinib (Imbruvica) than patients with another molecular subtype of the disease. The study appeared online July 20, 2015, in Nature Medicine.